3T Biosciences
PrivateLast Round
Series A
Aug 25, 2022
Total Funding Raised
$52M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
3T Biosciences is a biotechnology company that develops next-generation T-cell receptor (TCR)-based immunotherapies for solid tumors and immune-mediated diseases using a proprietary target discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3T Biosciences Comparables
Compare 3T Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoScape | 86% | |
| BlueSphere Bio | 84% | |
| Enara Bio | 82% | |
3T Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 25, 2022 | ||||
| Seed | Oct 5, 2017 |
Key People
Founding team and executive leadership
3T Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hayan Health Networks | Seed |
| Westlake Village BioPartners | Series A |
| Thiel Capital | Seed |
| Parker Institute for Cancer Immunotherapy | Seed, Series A |
| Asset Management Ventures | Seed |
| OS Fund | Seed |
| CRV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 58, 232% of headcount.
- Jun 18, 2026
Monthly visitors increased 60% MoM.
3T Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 3T Biosciences's valuation, stock price, and market status.